Chimeric Antigen Receptor (CAR) T-cell therapy: Revolutionizing Cancer Care Through Innovation and Regulation.
Year: 2025
Type: article
Abstract: Chimeric Antigen Receptor T-cell therapy, commonly known as CAR T-cell therapy, stands at the forefront of immunotherapy by transforming a patient’s own immune cells into powerful cancer fighters. This innovative treatment involves extracting T-cells, which are vital immune system components, from a patient’s blood, modifying them genetically to detect cancer specific markers, and returning them to the patient’s body to attack malignant cells. Unlike broad acting treatments like chemotherapy, CAR T-cell therapy zeroes in on cancer with precision, amplifying the body’s natural defenses through advanced engineering.
Authors: Patel, Khushboo, Sureja, Meri, Pirouzi, Peivand
Institution: Northeastern University
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6912162706
FWCI:
Cites:
Cited by:
Related to: